Moreau Violaine V

Show results for

Transcriptomics (2)
Proteomics (2)

Organisms

Homo sapiens (2)
Spongiibacter nanhainus (2)
Lemna minor (2)
Ciona intestinalis x Ciona robusta (2)
Achromobacter xylosoxidans A8 (2)
Human adenovirus 2 (2)
Rhodobacter capsulatus SB 1003 (2)
Nostoc sp. PCC 7120 = FACHB-418 (2)
Dreissena polymorpha (2)
Gazella dorcas (2)
Cervidae (2)
Diceros bicornis (2)
Rhinoceros unicornis (2)
Lepus sp. (2)
Vibrio (2)
Aepyceros melampus (2)
Giraffa camelopardalis (2)
Ammotragus lervia (2)
Lacrimispora saccharolytica (2)
sludge granule bacterium 1 (2)
Cygnus (2)
Pusa sibirica (2)
Phoca vitulina (2)
Tragelaphus spekii (2)
Palaeoloxodon (2)
Elephas maximus (2)
Palaemon serratus (2)
Sipunculus nudus (2)
Trypanosoma cruzi strain CL Brener (2)
Connochaetes gnou (2)

Repository

biostudies-arrayexpress (2)
pride (2)

Disease

Endometrial cancer (1)

Technology Type

Mass Spectrometry (2)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

NextSeq 2000 (2)
NEXTflex Small-RNA Seq kit v3 (Perkin Elmer) & NEXTflex Rapid XP DNA-seq kit v2 (Perkin Elmer) (1)
Direct-zol RNA microprep kit (Zymo Research), LabChip RNA pico sensitivity assay, Perkin Elmer & Nucleospin RNA kit (Macherey Nagel) (1)
PALM type 4 microscope (Zeiss) (1)

Publication Date

2026 (2)
2025 (1)
2024 (1)

Study type

MicroRNA profiling by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2026 (1)
2025 (1)

Lab affiliation

Univ. Bordeaux, INSERM, BRIC, U1312, Bordeaux, France. (1)
Univ. Bordeaux, INSERM, BRIC, U1312, Bordeaux, France (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer, a novel cancer-relevant paralog interplay

Endometrial cancer is one of the main gynecological malignancies worldwide, with an estimated 320 000 new cases annually. Several studies highlight ARHGAP35 as a significantly mutated gene in these tumors. It encodes for the protein p190RhoGAP-A (p190A), which is a major regulator of the small GTPas...

ORGANISM(S): Homo sapiens (Human)

2026-09-14 | PXD067294 | Pride

Loss of Rnd3/RhoE induces entosis in human hepatocellular carcinoma

Entosis is a process that leads to the formation of cell-in-cell structures commonly found in cancers. Here, we identified entosis in hepatocellular carcinoma and the loss of Rnd3 as an efficient inducer of this mechanism. We characterized the different stages and the molecular regulators of entosis...

ORGANISM(S): Homo sapiens (Human)

2024-01-26 | PXD043640 | Pride

Rnd3 Rhoa/rock Lamp-1 Hepatocellular carcinoma Cell-in-cell Entosis Tumor progression.

Small RNA seq of HepG2 cells expressing shRNA targeting wild-type, mutated or both ß-catenin versus shRNA control

HepG2 cells expressing doxycycline-inducible shRNA were treated by doxycycline for 7 days. Four stable cell lines were used: HepG2 cells expressing a control shRNA; HepG2 cells expressing a shRNA targeting wild-type ß-catenin ; HepG2 cells expressing a shRNA targeting mutated ß-catenin ; HepG2 cell...

ORGANISM(S): Homo sapiens

2026-09-03 | E-MTAB-15638 | biostudies-arrayexpress

RNA-seq of cancer cell collagen tracks

Collagen tracks deposited by breast cancer cells contain specific miRNAs which reprogram non-invasive cells into highly pro-metastatic ones by inducing a partial epithelial–mesenchymal transition (EMT) associated with an increase in ECM degradation and cell invasiveness.